Dr. Martens plc (LON:DOCS – Get Free Report) insider Ije Nwokori acquired 194 shares of Dr. Martens stock in a transaction dated Friday, July 11th. The shares were acquired at an average cost of GBX 77 ($1.03) per share, with a total value of £149.38 ($200.00).
Ije Nwokori also recently made the following trade(s):
- On Wednesday, June 11th, Ije Nwokori bought 189 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 79 ($1.06) per share, for a total transaction of £149.31 ($199.91).
Dr. Martens Trading Down 0.6%
Shares of Dr. Martens stock opened at GBX 79.35 ($1.06) on Wednesday. Dr. Martens plc has a 12-month low of GBX 43.02 ($0.58) and a 12-month high of GBX 83.30 ($1.12). The stock has a market capitalization of £770.30 million, a P/E ratio of 11.25, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a 50-day simple moving average of GBX 68.52 and a 200 day simple moving average of GBX 64.02. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.
Analyst Ratings Changes
DOCS has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Dr. Martens in a report on Friday, July 11th. Royal Bank Of Canada decreased their price target on Dr. Martens from GBX 7,000 ($93.72) to GBX 6,000 ($80.33) and set a “sector perform” rating on the stock in a research note on Monday, May 19th.
View Our Latest Stock Analysis on DOCS
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
- Five stocks we like better than Dr. Martens
- What is the FTSE 100 index?
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- What does consumer price index measure?
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- Ride Out The Recession With These Dividend Kings
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.